Living with Progressive Multiple Sclerosis? Take Part in Study to Develop Better Treatment Options
If you’re living with progressive MS, you may be able to join a clinical trial testing a potential new treatment that may slow decline, reduce relapses, and help people stay active for longer. These clinical trials are taking place in Christchurch and Auckland. Clinical trials are the backbone of medical progress, rigorously testing drugs and […]
Looking Back, Building Forward: Our 2025 Year in Review
As we close the year, we want to thank you, our members, donors, and supporters, for standing with Multiple Sclerosis NZ through another year of progress, advocacy and growing impact. Together, we have secured tangible advocacy wins, expanded education and awareness, strengthened our network of dedicated MS organisations, and continued to future-proof the organisation […]
Staying well with MS this Summer
Long, bright summer days of a traditional Kiwi summer are upon us. Sunshine boosts our mood, warms our skin, and encourages us to get outside and enjoy everything from bushwalks to backyard barbecues. For people living with multiple sclerosis (MS) the sun can still offer these benefits, but because MS interacts with heat and certain medications in unique ways it’s worth taking a thoughtful sun smart approach. The benefits […]
MS Voice e-Newsletter – December 2025
Welcome to our December 2025 Edition of MS Voice, your go-to place for the latest news, updates, and real life stories from Multiple Sclerosis New Zealand. In this edition, we share that we have once again been chosen as the masthead charity for the Bangers to Bluff Car Rally, provide you with the ECTRIMS Patient […]
Subcutaneous Ocrelizumab update.
From 1 December 2025, a new way of receiving ocrelizumab treatment will be available in Aotearoa New Zealand. Alongside the current intravenous (IV) infusion, people with MS will soon have the option of a subcutaneous (under-the-skin) injection. The subcutaneous formulation contains the same medication as the IV infusion but is delivered differently. For some, this […]
Ocrelizumab Subcut – Overcoming Barriers to Access – Pharmac Opens Consultation for Funding
After strongly advocating to Pharmac since July 2024, Multiple Sclerosis NZ welcomes the announcement today that Pharmac is opening public consultation for the funding of subcutaneous Ocrelizumab (Ocrevus). This funding comes as part of a multi-medicine deal between Pharmac and Roche. Ocrevus Subcutaneous (SC) is delivered by injection under the skin rather than by intravenous […]
MS Voice eNewsletter – July 2025
Welcome to our July 2025 Edition of MS Voice, your go-to place for the latest news, updates, and real life stories from Multiple Sclerosis New Zealand. In this edition we provide some tips for keeping warm and active this winter, update you on MS research happening in Aotearoa and inform you about immediate changes to […]
MS Diagnosis Jumps 67% in NZ, Exposing Māori Care Gaps
Neil Woodhams, President of Multiple Sclerosis New Zealand, joined Dale Husband on Waatea News to discuss the recent study which showed a 67% surge of MS diagnoses in New Zealand since 2006 and the Māori disparities that highlight the urgent need for Neurological care investment. Listen to their interview below: Alongside discussing the prevalence of […]
1News Report – Medsafe Approves 10 Minute Ocrevus Injection
Watch Graham Walker, person with MS, President of MS Taranaki and Co-Vice President of MSNZ discuss the life-changing news that Medsafe has approved the 10 minute Ocrevus injection, accompanied with comments from Amanda Rose, MSNZ National Manager on 1News, 29th April 2025. Watch here: https://www.youtube.com/watch?v=1YQitPAsR5A We encourage those with lived experience to provide their stories […]
MS Voice Newsletter – April 2025
Welcome to our April 2025 Edition of MS Voice, your go-to place for the latest news, updates, and real life stories from Multiple Sclerosis New Zealand. In this edition, we provide an overview of the hugely successful Bangers to Bluff 2025 car rally, update you on our disability support services submission, and announce that Medsafe […]